Secondary metabolites from Scindapsus officinalis (Roxb.) Schott. with in vitro antidiabetic activities

Lei Zhao,Yan Wang,Zhenqiang Wang,Tong Niu,Jinqian Yu,Tao Yue
DOI: https://doi.org/10.1016/j.fitote.2024.105822
IF: 3.204
2024-01-15
Fitoterapia
Abstract:One new phenolic cyclobutantetraol ester united chromone glycoside ( 1 ), one new amide ( 2 ), and three new phenyl ethanol glycosides ( 3 – 5 ) were obtained from the water extract of Scindapsus officinalis (Roxb.) Schott, in which compound 1 was the first reported structure incorporating the phenolic cyclobutantetraol ester and chromone via the glucose phenolic metabolites in nature. Structures of the isolated compounds, including absolute configurations, were elucidated according to the analysis of HRESIMS, NMR, ECD and BLYP/6-31G* geometry optimization calculations of 13 C NMR data. All isolates ( 1 – 5 ) were evaluated for the antidiabetic activity by the insulin resistance (IR) model and anti-inflammatory activity against NO production in vitro. Compounds 1 – 3 showed strong antidiabetic activities, greatly promoting the glucose consumption in the insulin resistance HepG2 cells compared with the model group, however, 1 – 5 showed weak anti-inflammatory activities.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?